Vaccine Treatment and Evaluation Units: Why Support a “Ready Base” of Clinical Trial Sites?
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Emily J Erbelding und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Ma…. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Vaccines, Vaccine Development. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The National Institute of Allergy and Infectious Diseases has funded a clinical trial infrastructure to advance products and strategies to improve treatment and prevention of infectious diseases. This infrastructure includes dedicated research clinics, such as the Vaccine and Treatment Evaluation Units (VTEUs). For more than 6 decades, the VTEUs have maintained quality systems to advance investigational products to licensure by conducting trials that de-risk private sector investment in clinical development. They have developed novel clinical trial approaches, such as controlled human challenge models, responded rapidly to pandemic threats, engaged impacted communities across a variety of diseases, and provided mentorship and training to the next generation of clinical investigators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Erbelding, E. J., & Marrazzo, J. M. (2025). Vaccine Treatment and Evaluation Units: Why Support a “Ready Base” of Clinical Trial Sites?. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf376
Vancouver
Erbelding EJ, Marrazzo JM. Vaccine Treatment and Evaluation Units: Why Support a “Ready Base” of Clinical Trial Sites?. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf376
BibTeX
@article{Erbelding2025,
author = {Erbelding, Emily J and Marrazzo, Jeanne M},
title = {Vaccine Treatment and Evaluation Units: Why Support a “Ready Base” of Clinical Trial Sites?},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf376}
}
EUVIMED